(Q33334195)

English

Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

metastatic breast cancer

1 reference

based on heuristic

inferred from title

George Fountzilas

6

object named as

G Fountzilas

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Athanasios Dimopoulos

2

object named as

M A Dimopoulos

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

C Nicolaides

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

E Samantas

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

D Bafaloukos

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

C Kalofonos

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

E Razi

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

P Kosmidis

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

N Pavlidis

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2000

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

873-875

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Advanced breast cancer: a phase II trial with gemcitabine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008361711049

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008361711049

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I pharmacologic study of a new Vinca alkaloid: navelbine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008361711049

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008361711049

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008361711049

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008361711049

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008361711049

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008361711049

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008361711049

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008361711049

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33334195&oldid=1672276899"